VALGANCICLOVIR
valganciclovir 50 mg/mL powder for oral liquid, 100 mL
VALGANCICLOVIR (9655E)
9655E
Manner of administration:Oral
Restriction 15800
Indication: Cytomegalovirus infection and disease
Restriction 15814
Indication: Cytomegalovirus infection and disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 11 | Max qty units: 11 | # of repeats: 5 | DPMQ: $4,346.10 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Valcyte | |||||
